TAXISENSI 1 FCO 1G/4 ML PADS FACIALES 100.00 PZA Laboratorio: GlaxoSmithKline (GSK) México

Description

Laboratorio: GlaxoSmithKline (GSK) México

00 S/G LANOLINA 1

PRINCIPIO ACTIVO: NITAZOXANIDA

Vía de administración: Inhalación por nebulización

PRINCIPIO ACTIVO: BESILATO DE BEPOTASTINA

TAXISENSI 1 FCO 1G/4 ML PADS FACIALES 100.00 PZA Laboratorio: GlaxoSmithKline (GSK) MéxicoCEFOTAXIMA 1. 00 G

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy